Serum small extracellular vesicle–associated snoRNA panel adds diagnostic value to CEA and CYFRA21–1 for non-small cell lung cancer: an exploratory single-center study
Liguang Wang, Mei Wang, Qun Zhang, Xinyi Li, Zhijun Zhang, Kangyu Wang · 2026
Read Serum small extracellular vesicle–associated snoRNA panel adds diagnostic value to CEA and CYFRA21–1 for non-small cell lung cancer: an exploratory single-center study by Liguang Wang, Mei Wang, Qun Zhang, Xinyi Li, Zhijun Zhang, Kangyu Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13612279.txt.
Description
Liguang Wang leads a six-author team building a blood test panel for the commonest lung cancer. Non-small cell lung cancer is usually found late, and the standard serum markers CEA and CYFRA21-1 miss many cases. Tiny RNA molecules called snoRNAs ride stably inside small vesicles in blood. The team screened vesicle RNA from patients and controls, then validated four candidate snoRNAs by PCR in 240 untreated patients and 205 healthy people.
The four-snoRNA panel alone scored an area under the curve of 0.924, edging past the two standard markers at 0.903. Combining all six markers lifted accuracy to 0.970, with sensitivity near 87 percent and specificity near 97 percent. Performance held in early-stage disease and in matched subsets. No single snoRNA tracked tumor features after corrections, so the value lies in the panel. The authors frame the work as exploratory, a candidate for validation rather than a clinic-ready test.
Catalog record
| CREATOR | Liguang Wang, Mei Wang, Qun Zhang, Xinyi Li, Zhijun Zhang, Kangyu Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |